Thomas Andrew Jackson

Thomas Andrew Jackson

Auto-generated profile, based on publicly available information

Thomas Andrew Jackson

Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Ageing Research Reviews
Verified
Journal Article
Open access
DWDaisy Wilson
Daisy Wilson
TJThomas Jackson
Thomas Jackson
ESElizabeth Sapey
Elizabeth Sapey
JLJanet Lord
Janet Lord
Frailty is a common negative consequence of ageing. Sarcopenia, the syndrome of loss of muscle mass, quality and strength, is more common in older adults and has been considered a precursor syndrome or the physical manifestation of frailty. The pathophysiology of both syndromes is incompletely described with multiple causes, inter-relationships and complex pathways proposed. Age-associated changes to the immune system (both immunesenescence, the decline in immune function with ageing, and inflammageing, a state of chronic inflammation) have been suggested as contributors to sarcopenia and frailty but a direct causative role remains to be established. Frailty, sarcopenia and immunesenescence are commonly described in older adults but are not ubiquitous to ageing. There is evidence that all three conditions are reversible and all three appear to share common inflammatory drivers. It is unclear whether frailty, sarcopenia and immunesenescence are separate entities that co-occur due to coincidental or potentially confounding factors, or whether they are more intimately linked by the same underlying cellular mechanisms. This review explores these possibilities focusing on innate immunity, and in particular associations with neutrophil dysfunction, inflammation and known mechanisms described to date. Furthermore, we consider whether the age-related decline in immune cell function (such as neutrophil migration), increased inflammation and the dysregulation of the phosphoinositide 3-kinase (PI3K)-Akt pathway in neutrophils could contribute pathogenically to sarcopenia and frailty.

1 January 2018 in Aging and disease
Verified
Journal Article
Open access
CWCarly Welch
Carly Welch
ZHZaki K. Hassan-Smith
Zaki K. Hassan-Smith
CGCarolyn Greig
Carolyn Greig
JLJanet M. Lord
Janet M. Lord
TJThomas A. Jackson
Thomas A. Jackson
There has been increasing interest and research into sarcopenia in community-dwelling older adults since the European Working Group on Sarcopenia in Older People (EWGSOP) agreed a consensus definition in 2010. Sarcopenia has been defined as loss of muscle mass with loss of muscle function (strength or physical performance), with measurements two Standard Deviations (SDs) below the mean of a young reference population. This definition does not necessitate longitudinal measurements, or the absence of acute illness and diagnosis can be made from single measurements. We hypothesise that hospitalisation, due to a combination of acute inflammatory burden and muscle disuse, leads to an acute decline in muscle mass and function and may lead to some individuals meeting criteria for sarcopenia, acutely, based on the EWGSOP definition. This may be partially recoverable or may lead to increased risk of developing sarcopenia long-term. We have denoted the term "acute sarcopenia" to refer to acute loss of muscle mass and function associated with hospitalisation. This review discusses some of the current available research in this context and also identifies some of the knowledge gaps and potential areas for future research.

25 September 2013 in Age and Ageing
Verified
Journal Article
Open access
PDF file
AMAlasdair M. J. Maclullich
Alasdair M. J. Maclullich
AAAtul Anand
Atul Anand
DDDaniel H. J. Davis
Daniel H. J. Davis
TJThomas Jackson
Thomas Jackson
ABAmanda J. Barugh
Amanda J. Barugh
CCColm Cunningham
Colm Cunningham
Delirium is one of the foremost unmet medical needs in healthcare. It affects one in eight hospitalised patients and is associated with multiple adverse outcomes including increased length of stay, new institutionalisation, and considerable patient distress. Recent studies also show that delirium strongly predicts future new-onset dementia, as well as accelerating existing dementia. The importance of delirium is now increasingly being recognised, with a growing research base, new professional international organisations, increased interest from policymakers, and greater prominence of delirium in educational and audit programmes. Nevertheless, the field faces several complex research and clinical challenges. In this article we focus on selected areas of recent progress and/or uncertainty in delirium research and practice. (i) Pathogenesis: recent studies in animal models using peripheral inflammatory stimuli have begun to suggest mechanisms underlying the delirium syndrome as well as its link with dementia. A growing body of blood and cerebrospinal fluid studies in humans have implicated inflammatory and stress mediators. (ii) Prevention: delirium prevention is effective in the context of research studies, but there are several unresolved issues, including what components should be included, the role of prophylactic drugs, and the overlap with general best care for hospitalised older people. (iii) Assessment: though there are several instruments for delirium screening and assessment, detection rates remain dismal. There are no clear solutions but routine screening embedded into clinical practice, and the development of new rapid screening instruments, offer potential. (iv) Management: studies are difficult given the heterogeneity of delirium and currently expert and comprehensive clinical care remains the main recommendation. Future studies may address the role of drugs for specific elements of delirium. In summary, though facing many challenges, the field continues to make progress, with several promising lines of enquiry and an expanding base of interest among researchers, clinicians and policymakers.

24 May 2020 in Maturitas
Verified
Journal Article
Closed access
ZMZeinab Majid
Zeinab Majid
CWCarly Welch
Carly Welch
JDJustine Davies
Justine Davies
TJThomas Jackson
Thomas Jackson

14 March 2017 in PLOS Medicine
Verified
Journal Article
Open access
PDF file
TJThomas A. Jackson
Thomas A. Jackson
JGJohn R. F. Gladman
John R. F. Gladman
RHRowan H. Harwood
Rowan H. Harwood
AMAlasdair M. J. MacLullich
Alasdair M. J. MacLullich
ESElizabeth L. Sampson
Elizabeth L. Sampson
DDDaniel H. J. Davis
Daniel H. J. Davis
In an Essay, Andrew Jackson and colleagues discuss challenges in the diagnosis and management of older people with dementia and delirium in acute hospitals.

24 August 2015 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
PDF file
TJThomas A Jackson
Thomas A Jackson
DWDaisy Wilson
Daisy Wilson
SRSarah Richardson
Sarah Richardson
JLJanet Lord
Janet Lord